Home > Financial Ratios > NGL FINECHEM

NGL FINECHEM
Working Capital/Sales

    Back to All Ratios
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Working Capital/Sales(x) 3.963.192.692.662.94

What is the latest Working Capital/Sales ratio of NGL FINECHEM ?

The latest Working Capital/Sales ratio of NGL FINECHEM is 3.96 based on Mar2026 Consolidated results.
Year Working Capital/Sales
Mar20263.96
Mar20253.19
Mar20242.69
Mar20232.66
Mar20222.94

How is Working Capital/Sales of NGL FINECHEM Trending?

Years Working Capital/Sales % Change
Mar2026 3.96
24.14
Mar2025 3.19
18.59
Mar2024 2.69
1.13
Mar2023 2.66
-9.52
Mar2022 2.94 -

Other Financial Ratios of NGL FINECHEM


Compare Working Capital/Sales ratio of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹1,588.8 Cr -8.6% -26% 79% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹440,278.0 Cr -2.5% -4.7% 15.5% Stock Analytics
DIVIS LABORATORIES ₹243,966.0 Cr -4% 8.1% 55.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,478.0 Cr -2.3% 0.2% 36.6% Stock Analytics
CIPLA ₹109,950.0 Cr -1.7% -6.1% -12% Stock Analytics
DR REDDYS LABORATORIES ₹95,967.4 Cr -0.2% -4.4% -10.2% Stock Analytics


NGL FINECHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-8.6%

-26%

79%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses